Corinna Sorenson

Summary

Affiliation: London School of Economics
Country: UK

Publications

  1. doi request reprint Medical technology procurement in Europe: a cross-country comparison of current practice and policy
    Corinna Sorenson
    LSE Health, London School of Economics, Cowdray House, London, UK
    Health Policy 100:43-50. 2011
  2. doi request reprint Reflections on the evolution of health technology assessment in Europe
    Corinna Sorenson
    Research Fellow in Health Policy, London School of Economics, London, UK
    Health Econ Policy Law 7:25-45. 2012
  3. pmc Medical technology as a key driver of rising health expenditure: disentangling the relationship
    Corinna Sorenson
    LSE Health, London School of Economics and Political Science, London, UK European Health Technology Institute for Socioeconomic Research, Brussels, Belgium
    Clinicoecon Outcomes Res 5:223-34. 2013
  4. doi request reprint Evolving reimbursement and pricing policies for devices in Europe and the United States should encourage greater value
    Corinna Sorenson
    London School of Economics and Political Science, UK
    Health Aff (Millwood) 32:788-96. 2013
  5. doi request reprint Valuing end-of-life care in the United States: the case of new cancer drugs
    Corinna Sorenson
    London School of Economics and Political Science, LSE Health, London, UK
    Health Econ Policy Law 7:411-30. 2012
  6. doi request reprint Comparative effectiveness research: the experience of the National Institute for Health and Clinical Excellence
    Corinna Sorenson
    London School of Economics, London WC2A 2AE, United Kingdom
    J Clin Oncol 30:4267-74. 2012
  7. ncbi request reprint Use of comparative effectiveness research in drug coverage and pricing decisions: a six-country comparison
    Corinna Sorenson
    LSE Health, London School of Economics and Political Science, England
    Issue Brief (Commonw Fund) 91:1-14. 2010
  8. doi request reprint Applying health economics for policy decision making: do devices differ from drugs?
    Corinna Sorenson
    London School of Economics and Political Science, LSE Health, Houghton Street, London, UK
    Europace 13:ii54-8. 2011
  9. doi request reprint Public financing of IVF: a review of policy rationales
    Philipa Mladovsky
    London School of Economics, LSE Health, Cowdray House, Houghton Street, London, WC2A 2AE, UK
    Health Care Anal 18:113-28. 2010

Detail Information

Publications9

  1. doi request reprint Medical technology procurement in Europe: a cross-country comparison of current practice and policy
    Corinna Sorenson
    LSE Health, London School of Economics, Cowdray House, London, UK
    Health Policy 100:43-50. 2011
    ..More research is needed, however, to substantiate the role and influence of procurement on balancing the adoption and affordability of medical technologies...
  2. doi request reprint Reflections on the evolution of health technology assessment in Europe
    Corinna Sorenson
    Research Fellow in Health Policy, London School of Economics, London, UK
    Health Econ Policy Law 7:25-45. 2012
    ....
  3. pmc Medical technology as a key driver of rising health expenditure: disentangling the relationship
    Corinna Sorenson
    LSE Health, London School of Economics and Political Science, London, UK European Health Technology Institute for Socioeconomic Research, Brussels, Belgium
    Clinicoecon Outcomes Res 5:223-34. 2013
    ....
  4. doi request reprint Evolving reimbursement and pricing policies for devices in Europe and the United States should encourage greater value
    Corinna Sorenson
    London School of Economics and Political Science, UK
    Health Aff (Millwood) 32:788-96. 2013
    ....
  5. doi request reprint Valuing end-of-life care in the United States: the case of new cancer drugs
    Corinna Sorenson
    London School of Economics and Political Science, LSE Health, London, UK
    Health Econ Policy Law 7:411-30. 2012
    ..A number of initial steps are discussed that could be pursued to improve the value of advanced cancer care...
  6. doi request reprint Comparative effectiveness research: the experience of the National Institute for Health and Clinical Excellence
    Corinna Sorenson
    London School of Economics, London WC2A 2AE, United Kingdom
    J Clin Oncol 30:4267-74. 2012
    ..To assess the relevance of the experience of the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom to the comparative effectiveness research (CER) initiative in the United States...
  7. ncbi request reprint Use of comparative effectiveness research in drug coverage and pricing decisions: a six-country comparison
    Corinna Sorenson
    LSE Health, London School of Economics and Political Science, England
    Issue Brief (Commonw Fund) 91:1-14. 2010
    ..In turn, use of CER creates incentives for more efficient, high-quality health care and encourages development of innovative products that offer measurable value to patients...
  8. doi request reprint Applying health economics for policy decision making: do devices differ from drugs?
    Corinna Sorenson
    London School of Economics and Political Science, LSE Health, Houghton Street, London, UK
    Europace 13:ii54-8. 2011
    ....
  9. doi request reprint Public financing of IVF: a review of policy rationales
    Philipa Mladovsky
    London School of Economics, LSE Health, Cowdray House, Houghton Street, London, WC2A 2AE, UK
    Health Care Anal 18:113-28. 2010
    ....